You pick up your prescription, follow the dosage, and trust that it will do its job. For many people, that routine rarely raises concern.
But emerging research suggests that some widely used medications may carry risks that are not always fully understood.
According to reporting by Times of India, citing a study published in PLOS Medicine and conducted by researchers at University College London, drugs such as gabapentin and pregabalin are now under closer scrutiny.
A closer look
These medications are commonly used to treat nerve pain, anxiety, and sleep disorders. They have often been viewed as a safer alternative to stronger painkillers.
Also read: Study documents unusual tick-related arthritis cases
However, researchers examined data from nearly 17,000 patients in the UK and identified a concerning pattern.
The risk of drug poisoning was already elevated in the period leading up to treatment and remained higher during the early phase after the medication was introduced.
This suggests that patients may already be in a vulnerable state before starting these drugs.
When risks increase
The study also highlights how combining medications can amplify the danger. Many patients receiving these treatments are also prescribed other drugs, which can complicate the overall risk profile.
Also read: Early signs of hantavirus you need to know
Key factors linked to higher risk include:
- Use alongside opioids
- Combination with benzodiazepines
- Multiple ongoing prescriptions
Such combinations were associated with a significantly increased likelihood of poisoning, reflecting trends seen in both UK and US data.
A need for caution
Researchers emphasize that these medications remain beneficial for many patients when used appropriately.
However, the assumption that they are universally low-risk is increasingly being questioned.
Also read: 39-year-old mother ignored cancer symptoms - now she warns others
The findings point to the importance of careful prescribing and closer monitoring, particularly for patients taking multiple medications.
Also read: Earlier treatment for heart failure may benefit patients, study finds